Generic Drugs Market Research Reports & Industry Analysis
Prescription generic pharmaceuticals are the non-patented chemical and therapeutic equivalents of brand-name drugs. These low-cost alternatives must contain the same active chemical ingredient and rate of absorption as the branded product. Due to high demand an increase in the number of generic drug approvals, the global generic drugs market has expanded at a steady pace over the years, and new growth opportunities are anticipated in the future. Check out our research collection to learn more about this lucrative market.
New Generic Drugs Industry Research
- Find quality data on industries big and small, whether you are interested in a specific product, region, or country.
- Gain in-depth research on generic drug market segmentation, patents, clinical trials, funding, and regulatory framework.
- Discover valuable new market opportunities, pockets of growth, and strategies to sustain success.
A Trusted Name in Research
MarketResearch.com offers a wealth of resources to propel your success through data-driven decision-making. We are proud to serve top investment banks, management consulting firms, leading life science companies, and universities—with a track record spanning decades and an experienced team to support your research needs. Explore our generic drugs industry reports today and embrace the power of foresight in an evolving market.
Generics Drugs Industry Research & Market Reports
-
Pulmonary Arterial Hypertension Market Size, Trends, Analysis, and Outlook By Class (Endothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors. Prostacyclin and Prostacyclin Analogs, SGC Stimulators), By Type (Branded, Generics), By Route of Administration (Oral, Intravenous/ subcutaneous, Inhalational), by Region, Country, Segment, and Companies, 2024-2030
... by Region, Country, Segment, and Companies, 2024-2030 The global Pulmonary Arterial Hypertension market size is poised to register 5.93% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Generic Pharmaceuticals Contract Manufacturing Market Size, Trends, Analysis, and Outlook By Drug (Branded Generics, Unbranded Generics), By Product (API, Drug Product), By Route of Administration (Oral, Parenteral, Topical, Others), By Application (Oncology, Immunology, Antidiabetic, Neurology, Anticoagulants, Cardiovascular, Respiratory, Pain, HIV Antivirals, Others), by Region, Country, Segment, and Companies, 2024-2030
... Anticoagulants, Cardiovascular, Respiratory, Pain, HIV Antivirals, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Generic Pharmaceuticals Contract Manufacturing market size is poised to register 6.62% growth from 2024 to 2030, presenting significant growth ... Read More
-
Myelodysplastic Syndrome Drugs Market Size, Trends, Analysis, and Outlook By Therapeutic Class (Hypomethylating Agents, Immunomodulatory Drugs, Anti-Anemics), By Type Of Syndrome (Refractory Cytopenia With Multilineage Dysplasia, Refractory Anemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Ringed Sideroblasts), By Route of Administration (Oral, Parenteral), By Application (Original, Generics), By End-user (Hospitals, Clinics, Ambulatory Surgical Centers), by Region, Country, Segment, and Companies, 2024-2030
... With Ringed Sideroblasts), By Route of Administration (Oral, Parenteral), By Application (Original, Generics), By End-user (Hospitals, Clinics, Ambulatory Surgical Centers), by Region, Country, Segment, and Companies, 2024-2030 The global Myelodysplastic Syndrome Drugs market size is ... Read More
-
The 2025-2030 World Outlook for Influenza Medications
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Cold-Chain Generic Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Generics in Antivirals
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Generic Prescription Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Generic Injectables
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Inhalation and Nasal Spray Generic Corticosteroid Drugs
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
The 2025-2030 World Outlook for Branded Generics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Inhalation and Nasal Spray Generic Drugs
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Specialty Generics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Generic Biosimilar Large Molecule Injectables
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Generic Oncology Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Generic Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Generic Biosimilars
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Generic Antiviral Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Pure Generic Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Generic Inhalation and Nasal Spray Drugs
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Specialty Injectable Generics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
2024 Global Forecast for Inhalation And Nasal Sprays Generic Drugs Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... for over 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase ... Read More
-
Global Inhalation and Nasal Spray Generic Drugs Market Growth 2024-2030
... 2023. With growing demand in downstream market, the Inhalation and Nasal Spray Generic Drugs is forecast to a readjusted size of US$ 3796.1 million by 2030 with a CAGR of 4.8% during review period. The ... Read More
-
Progesterone Market Size - By Formulation (Natural, Synthetic), Route of Administration (Injectable, Oral), Application (Contraception, Menopause), Drug Type (Generic, Branded), Type (Prescription, OTC), Distribution Channel & Forecast, 2024 - 2032
... to witness 12.7% CAGR between 2024 and 2032, owing to increasing awareness and diagnosis of hormone-related disorders, such as polycystic ovary syndrome (PCOS), infertility, and menstrual irregularities. As per WHO, in 2023, PCOS affected an ... Read More
-
Active Pharmaceutical Ingredient (API) Market in US 2024-2028
... period. The report on the active pharmaceutical ingredient (API) market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The ... Read More
-
Pharma Wholesale and Distribution Market Report 2024-2034
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increasing Government Initiatives for Pharmaceutical Products ... Read More
Research Assistance
